If you made any changes in Pure these will be visible here soon.

Personal profile


Paul Liknaitzky is Head of Clinical Psychedelic Research at Monash University, and Chief Principal Investigator on a program of psychedelic trials at Monash University. He is a joint Research Fellow within the Turner Institute (School of Psychological Sciences) and the Dept of Psychiatry (School of Clinical Sciences) at Monash University. Paul has an Honours in Neuroscience and a PhD in Psychology from the University of Melbourne, and has Adjunct or Honorary appointments at St Vincent’s Hospital, Macquarie University, Deakin University, and the University of Melbourne. He is an Investigator on a number of Australia’s first few ethically-approved psychedelic trials, coordinates Australia’s first applied psychedelic therapist training programs, has obtained the first industry funding and partnership for psychedelics in Australia, is establishing Australia’s largest psychedelic trial, and leads Australia’s first clinical psychedelic lab. His work is focused on developing a rigorous program of research in psychedelic medicine that seeks to evaluate therapeutic effects, innovate on treatment design, mitigate known risks, explore potential drawbacks, and understand therapeutic mechanisms.

Education/Academic qualification

Neuroscience, BSc (Hons), University of Melbourne

Psychological Sciences, PhD, University of Melbourne

Neuroscience, BSc, University of Western Australia

External positions

Honorary Research Fellow, Deakin University

Adjunct Research Fellow, St Vincent's Hospital Melbourne

Honorary Research Fellow, Swinburne University of Technology

Honorary Research Fellow, University of Melbourne

Research area keywords

  • Psychedelic medicine
  • Mood Disorders
  • Addiction
  • Post-traumatic Stress Disorder
  • Obsessive Compulsive Disorder
  • Depressive cognition
  • Transdiagnostic mechanisms of psychopathology


Recent external collaboration on country/territory level. Dive into details by clicking on the dots or